Tag: current global market

Morepen Labs Adds three New Drugs – Rivaroxaban, Vildagliptin and UDCA to its API Portfolio

New Delhi, Delhi, India, 14th October 2019: Morepen Laboratories Ltd. has developed and added three blockbuster drugs to its...